醫思健康(02138.HK)擬1575萬港元收購獸醫業務
格隆匯4月7日丨醫思健康(02138.HK)發佈公吿,2022年4月6日,公司及其全資附屬公司(作為買方)與(其中包括)一名在香港註冊的獸醫(作為賣方)訂立一份有條件的買賣協議,據此,賣方有條件同意出售一家在大埔經營獸醫醫院的目標公司的75%已發行股本,總代價為1575萬港元。
目標公司在香港提供獸醫服務。根據由賣方提供的截止2021年10月31日止7個月的未經審計財務資料,目標公司於該期間的税後溢利約為260萬港元。截至該公吿日期,目標公司於大埔經營一間獸醫醫院,擁有4名註冊獸醫。受制於協議的條款,賣方向集團保證(其中包括)目標公司於完成收購後共三年的累計經審計的税後溢利將不少於1050萬港元。
公吿表示,集團自2021年開展獸醫業務,並積極尋求拓展該市場的機會。監於香港對獸醫服務的需求不斷增長,公司旨在整合獸醫市場,並促進香港獸醫業務企業化。公司對目標公司的前景樂觀,並認為收購事項將(其中包括)使目標公司業務與集團業務產生協同效應;使集團業務組合多樣化;為集團提供新收入來源;及為集團現有業務提供新客源。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of this article is for reference only. It does not constitute an offer, solicitation, recommendation, opinion or guarantee of any securities, financial products or instruments.The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance.